Stealth BioTherapeutics
ApprovedDeveloping new biotherapeutic treatments for patients with genetic mitochondrial diseases and common diseases of aging.
Founded
2006
Focus
Small Molecules
About
Developing new biotherapeutic treatments for patients with genetic mitochondrial diseases and common diseases of aging.
Funding History
5Total raised: $280M
PIPE$40MRedmile GroupDec 15, 2020
IPO$70MUndisclosedJan 31, 2019
Series C$80MRedmile GroupJun 15, 2018
Series B$60MRedmile GroupJun 15, 2016
Company Info
TypePrivate
Founded2006
LocationNewton, United States
StageApproved
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile